The Same Homozygous Pathogenic Variant in CHAT Underlies Lethal Fetal Akinesia Syndrome in Three Xhosa South African Fetuses Authors: Jade Ramini, Cumine van Tonder, Yolandi Swart, Kerry Rademan, Samantha Budhram, Lut Geerts, Shahida Moosa Published: 2026 ABSTRACT Key Summary What is already known about this topic?◦Biallelic pathogenic variants in CHAT cause congenital myasthenic syndrome (CMS), typically presenting postnatally with episodic apnea and neuromuscular weakness. CHAT encodes choline acetyltransferase, essential for acetylcholine synthesis at the neuromuscular junction, and previously has not been associated with uniformly lethal prenatal phenotypes.What does this study add?◦We demonstrate that biallelic CHAT variants can cause severe fetal akinesia resulting in lethal multiple pterygium syndrome, expanding the phenotypic spectrum to include presentation, lethality and supporting inclusion of CHAT in fetal akinesia gene panels. Keywords: CHAT, exome sequencing, fetal akinesia, lethal multiple pterygium syndrome, South Africa Fetal Phenotype All three fetuses were of Xhosa ancestry and pregnancies were characterized by decreased fetal movement. Fetuses 1 and 2 were evaluated at the Fetal Medicine Unit, where antenatal ultrasounds demonstrated a recognizable pattern consistent with fetal akinesia and athrogryposis multiplex congenita: micrognathia (2/2), nuchal edema (2/2), narrow chest (2/2), and multiple fixed flexion contractures at all joints (2/2) (Table 1). TABLE 1Clinical data of fetuses with the homozygous pathogenic CHAT variant.CaseParental detailsGestation at diagnosisPhenotypes (HPO terms)Obstetric historyFamily historyOutcome1MaternalAge3227 + 2 Prenatal: Decreased fetal movement Micrognathia Fetal nuchal edema Scoliosis Thoracic hypoplasia Fixed elbow flexion Wrist flexion contracture Hip flexion contracture Knee flexion contracture Postnatal: Short neck Webbed neck Low posterior hairline Thickened nuchal skin fold Highly arched eyebrow Depressed nasal bridge Kyphoscoliosis Pierre‐robin sequence Micrognathia Cleft palate Overlapping fingers Arthrogryposis multiplex congenita Multiple pterygia HP:0001558 HP:0000347 HP:0034250 HP:0002650 HP:0005257 HP:0006471 HP:0001239 HP:0020025 HP:0006380 HP:0000470 HP:0000465 HP:0002162 HP:0000474 HP:0002553 HP:0005280 HP:0002751 HP:0000201 HP:0000347 HP:0000175 HP:0010557 HP:0002804 HP:0001040 G2P1 Nil Non‐consanguineous Medical termination of pregnancy (MTOP) at 28 + 1 weekEthnicityXhosaPaternalAgeUnknownEthnicityXhosa2MaternalAge1922 + 2 Prenatal: Micrognathia Depressed nasal bridge Fetal nuchal edema Hydrops fetalis Fetal pleural effusion Narrow chest Overlapping fingers Rocker bottom foot Arthrogryposis multiplex congenita Postnatal: Short neck Thickened nuchal skin fold Low‐set ears Depressed nasal bridge Arthrogryposis multiplex congenita Multiple pterygia HP:0000347 HP:0005280 HP:0034250 HP:0001789 HP:0025676 HP:0000774 HP:0010557 HP:0001838 HP:0002804 HP:0000470 HP:0000474 HP:0000369 HP:0005280 HP:0002804 HP:0001040 G1P0 Nil Non‐consanguineous Medical termination of pregnancy (MTOP) at 22 + 2 weeksEthnicityXhosaPaternalAge22EthnicityXhosa3MaternalAge36Unknown Prenatal: No prenatal follow‐up, but mother noted Decreased fetal movement Postnatal: Maceration Short neck Thickened nuchal skin fold Low‐set ears Depressed nasal bridge Thoracic kyphosis Pectus carinatum Arthrogryposis multiplex congenita Multiple pterygia HP:0001558 HP:0032007 HP:0000470 HP:0000474 HP:0000369 HP:0005280 HP:0002942 HP:0000768 HP:0002804 HP:0001040 G3P2 Nil Non‐consanguineous Intra‐uterine fetal demise (IUFD)—stillbirth Estimated gestation +/− 28 weeks EthnicityXhosaPaternalAgeUnknownEthnicityXhosa Clinical data of fetuses with the homozygous pathogenic CHAT variant. Prenatal: Decreased fetal movement Micrognathia Fetal nuchal edema Scoliosis Thoracic hypoplasia Fixed elbow flexion Wrist flexion contracture Hip flexion contracture Knee flexion contracture Postnatal: Short neck Webbed neck Low posterior hairline Thickened nuchal skin fold Highly arched eyebrow Depressed nasal bridge Kyphoscoliosis Pierre‐robin sequence Micrognathia Cleft palate Overlapping fingers Arthrogryposis multiplex congenita Multiple pterygia HP:0001558 HP:0000347 HP:0034250 HP:0002650 HP:0005257 HP:0006471 HP:0001239 HP:0020025 HP:0006380 HP:0000470 HP:0000465 HP:0002162 HP:0000474 HP:0002553 HP:0005280 HP:0002751 HP:0000201 HP:0000347 HP:0000175 HP:0010557 HP:0002804 HP:0001040 Nil Non‐consanguineous Prenatal: Micrognathia Depressed nasal bridge Fetal nuchal edema Hydrops fetalis Fetal pleural effusion Narrow chest Overlapping fingers Rocker bottom foot Arthrogryposis multiplex congenita Postnatal: Short neck Thickened nuchal skin fold Low‐set ears Depressed nasal bridge Arthrogryposis multiplex congenita Multiple pterygia HP:0000347 HP:0005280 HP:0034250 HP:0001789 HP:0025676 HP:0000774 HP:0010557 HP:0001838 HP:0002804 HP:0000470 HP:0000474 HP:0000369 HP:0005280 HP:0002804 HP:0001040 Nil Non‐consanguineous Prenatal: No prenatal follow‐up, but mother noted Decreased fetal movement Postnatal: Maceration Short neck Thickened nuchal skin fold Low‐set ears Depressed nasal bridge Thoracic kyphosis Pectus carinatum Arthrogryposis multiplex congenita Multiple pterygia HP:0001558 HP:0032007 HP:0000470 HP:0000474 HP:0000369 HP:0005280 HP:0002942 HP:0000768 HP:0002804 HP:0001040 Nil Non‐consanguineous Intra‐uterine fetal demise (IUFD)—stillbirth Estimated gestation +/− 28 weeks Diagnostic Method Comprehensive clinical examinations were undertaken following delivery (Images of Fetus 2 ‐Figure 1A‐D) and post‐natal findings were correlated with antenatal ultrasound imaging, in the two prenatally detected cases. DNA was extracted from post‐mortem fetal skin biopsies. Singleton exome sequencing was performed as described previously [1]. Clinical photographs of Fetus 2. (A) Frontal view showing relatively larger head, short neck with pterygium, down‐slanted palpebral fissures, anteverted nares, long philtrum, small mouth with thin vermillion borders, contractures and pterygia at elbows, wrists and knees. (B) Profile view showing low‐set, posteriorly rotated ears, dimples over shoulder joint, contractures at elbows and knees. (C) Close‐up image of pterygium at the knee with rocker‐bottom feet. (D) Close‐up image of pterygium at the left elbow. Diagnostic Results and Interpretation A homozygous pathogenic variant in CHAT, NM_020549.5: c.605 T > G (p.Met202Arg) (see VariantValidatorReport) [2], was identified in the three unrelated Xhosa fetuses (Table 2). For Fetus 1 and 2, the variant was located in a run of homozygosity (ROH) of 9 and 2kb, respectively. This missense variant is rare in population databases (gnomAD 86/1613622 heterozygotes, 0 homozygotes) with an allele frequency of 0.00005330. Notably, the African/African American allele frequency is 0.001053. There are 5 other Xhosa carriers in our in‐house database. In silico prediction tools predict a deleterious impact on the protein (e.g., REVEL = 0.94). It has been reported in ClinVar (ID: 430062) underlying familial infantile myasthenia (OMIM 254210). It affects a highly conserved residue within the active site tunnel of CHAT. Functional studies have demonstrated a severe reduction in catalytic activity, with < 10% residual enzymatic function [3]. TABLE 2Genetic findings.CaseProcedure (gest age)Performed testSecondary confirmatory testGene (name; REFSEQ)Known disease (OMIM)VariantACMG classifi‐cationCriteria appliedInheritance & zygosityInterpretation1 Postmortem tissue biopsy MTOP at 28 + 1 week Exome sequencingN/A CHAT; NM_020549.5 Myasthenic syndrome, congenital, 6, presynaptic #OMIM254210 Allele 1: c.605 T > G (p.Met202Arg) Allele 2: c.605 T > G (p.Met202Arg) Pathogenic Pathogenic PM3, PS3, PM2, PM1, PP3 Autosomal recessive; Homozygous The homozygous CHAT c.605 T > G (p.Met202Arg) variant consistent with autosomal recessive inheritance (PM3). The variant is extremely rare in population databases (PM2) and affects a highly conserved residue within the catalytic domain of choline acetyltransferase (PM1). Multiple computational tools predict a deleterious effect (PP3), and functional studies demonstrate markedly reduced enzymatic activity (PS3). 2 Postmortem tissue biopsy MTOP at 22 + 2 weeks Exome sequencingN/A CHAT; NM_020549.5 Myasthenic syndrome, congenital, 6, presynaptic #OMIM254210 Allele 1: c.605 T > G (p.Met202Arg) Allele 2: c.605 T > G (p.Met202Arg) Pathogenic Pathogenic PM3, PS3, PM2, PM1, PP3 Autosomal recessive; Homozygous Same as above3 Postmortem tissue biopsy IUFD at +/− 28 weeks Exome sequencingN/A CHAT; NM_020549.5 Myasthenic syndrome, congenital, 6, presynaptic #OMIM254210 Allele 1: c.605 T > G (p.Met202Arg) Allele 2: c.605 T > G (p.Met202Arg) Pathogenic Pathogenic PM3, PS3, PM2, PM1, PP3 Autosomal recessive; Homozygous Same as above Genetic findings. Postmortem tissue biopsy MTOP at 28 + 1 week Myasthenic syndrome, congenital, 6, presynaptic #OMIM254210 Allele 1: c.605 T > G (p.Met202Arg) Allele 2: c.605 T > G (p.Met202Arg) Pathogenic Pathogenic PM3, PS3, PM2, PM1, PP3 Autosomal recessive; Homozygous The homozygous CHAT c.605 T > G (p.Met202Arg) variant consistent with autosomal recessive inheritance (PM3). The variant is extremely rare in population databases (PM2) and affects a highly conserved residue within the catalytic domain of choline acetyltransferase (PM1). Multiple computational tools predict a deleterious effect (PP3), and functional studies demonstrate markedly reduced enzymatic activity (PS3). Postmortem tissue biopsy MTOP at 22 + 2 weeks Myasthenic syndrome, congenital, 6, presynaptic #OMIM254210 Allele 1: c.605 T > G (p.Met202Arg) Allele 2: c.605 T > G (p.Met202Arg) Pathogenic Pathogenic PM3, PS3, PM2, PM1, PP3 Autosomal recessive; Homozygous Postmortem tissue biopsy IUFD at +/− 28 weeks Myasthenic syndrome, congenital, 6, presynaptic #OMIM254210 Allele 1: c.605 T > G (p.Met202Arg) Allele 2: c.605 T > G (p.Met202Arg) Pathogenic Pathogenic PM3, PS3, PM2, PM1, PP3 Autosomal recessive; Homozygous Pregnancy Outcome Two fetuses were observed within our multidisciplinary prenatal genetic service. Parents were counseled regarding the ultrasound findings and poor prognosis associated with severe fetal akinesia, informed by prior clinical experience of in utero demise in similar cases. Following counseling, both pregnancies were medically terminated, and postmortem genetic testing was requested. Fetus 3 presented following reduced fetal movement around 28 weeks of gestation and was diagnosed with intrauterine fetal demise. The mother consented to postmortem genetic testing after counseling by the medical genetics team. Discussion Fetal akinesia deformation sequence (FADS) encompasses a heterogeneous group of severe disorders characterized by reduced or absent fetal movement, leading to secondary anomalies including arthrogryposis, pterygia, pulmonary hypoplasia, craniofacial abnormalities, and fetal or neonatal demise. Lethal multiple pterygium syndrome (LMPS) represents the most severe end of this spectrum. The underlying mechanism typically involves disruption of neuromuscular transmission during critical developmental periods [4]. To date, pathogenic variants in several genes involved in neuromuscular transmission, including CHRNG, CHRNA1, CHRND, MUSK, RAPSN, and DOK7, have been implicated in both lethal fetal phenotypes and non‐lethal congenital myasthenic syndromes (CMS), highlighting a continuum of disease severity depending on the timing and extent of neuromuscular impairment. In contrast, biallelic pathogenic variants in CHAT have classically been associated with non‐lethal CMS, characterized by episodic aponia, respiratory distress, swallowing difficulty, hypotonia, and muscle weakness presenting in the neonatal or infantile period rather than with a uniformly lethal prenatal disorder [5]. Over the last decade, we have encountered dozens of similar Xhosa fetuses, none of whom survived. We report on three unrelated South African fetuses with antenatal features consistent with severe FADS and postmortem findings indicative of LMPS who share a pathogenic missense variant in CHAT. The severe phenotype associated with this CHAT variant is consistent with the critical role of residue p.Met202 in catalysis, and prior functional studies showing very low residual enzyme activity for the p.Met202Arg variant. This observation expands the phenotypic spectrum associated with variants in CHAT to include a prenatal lethal neuromuscular phenotype, paralleling other neuromuscular junction genes, particularly CHRNA1, CHRND, and CHRNG (OMIM 253290). This case series provides novel evidence that CHAT‐related disease exists on a severity continuum extending from lethal fetal akinesia to survivable postnatal CMS, with important implications for prenatal diagnosis, genetic counseling, and recurrence risk assessment. Furthermore, the value of comprehensive genomic investigation in African populations, where recurrent pathogenic variants may reveal previously unrecognized genotype–phenotype correlations, is illustrated. Funding This work was supported by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the (1) Early Investigators Programme from funding received from the South African National Treasury, (2) SIR Grant (2024–2026), and (3) the SAMRC Centre for Tuberculosis Research, Faculty of Medicine and Health Sciences, Stellenbosch University. The content hereof is the sole responsibility of the authors and does not necessarily represent the official views of the SAMRC. Ethics Statement This study was approved by the Human Research Ethics Committee (HREC) of Stellenbosch University (N18/03/031). Consent Written informed consent was obtained for enrollment in the Undiagnosed Disease Programme. The mothers consented to genetic testing, clinical photographs and publication. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments We thank the mothers for allowing our team the opportunity to provide care during this difficult experience and to establish the cause of the fetal anomalies. We also acknowledge the clinical teams involved in caring for these families. We gratefully acknowledge ilifu (https://www.ilifu.ac.za/) and the Centre for High Performance Computing (CHPC, http://www.chpc.ac.za) for computational resources. All sequencing was performed at the SAMRC Genomics Platform, Cape Town, South Africa. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.